Clearstead Advisors, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 842775
CLEVELAND, OH
Position in REGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$421,513
-$454,660 QoQ
Shares Held
676
-40.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#849
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Clearstead Advisors, LLC holds $22,018,760 across 201 Biotechnology names. REGN ranks #10 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VIR |
Vir Biotechnology, Inc.
|
608,234 | $6,197,904 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
341,711 | $2,991,679 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,510 | $2,240,252 | |
| 4 | BEAM |
Beam Therapeutics Inc.
|
60,620 | $2,080,478 | |
| 5 | NAUT |
Nautilus Biotechnology, Inc.
|
892,787 | $1,669,511 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
13,058 | $718,190 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
3,813 | $714,098 | |
| 8 | SANA |
Sana Biotechnology, Inc.
|
170,739 | $595,879 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $421,513 | 676 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $876,173 | 1,134 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $855,231 | 1,108 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $497,608 | 885 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $230,475 | 439 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $349,460 | 551 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $363,288 | 510 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $505,646 | 481 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $529,719 | 504 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $416,758 | 433 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $420,700 | 479 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $380,207 | 462 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $344,180 | 479 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $373,038 | 454 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $235,205 | 326 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $205,972 | 299 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $176,747 | 299 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $208,827 | 299 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $188,824 | 299 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $49,624 | 82 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $45,800 | 82 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $49,206 | 104 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $33,334 | 69 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $37,505 | 67 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $32,429 | 52 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $25,391 | 52 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||